When was Phylos Bioscience founded?

Phylos Bioscience was founded in 2014 and raised its 1st funding round 1 year after it was founded.

Where is Phylos Bioscience located?

Phylos Bioscience is headquartered in Portland, United States.

Who is the current CEO of Phylos Bioscience?

Mowgli Holmes of Phylos Bioscience.

How many employees does Phylos Bioscience have?

As of Sep 30, 2026, the latest employee count at Phylos Bioscience is 47.

Is Phylos Bioscience a funded company?

Phylos Bioscience is a funded company, having raised a total of $31.2M across 10 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on Jan 20, 2015.

When was the latest funding round of Phylos Bioscience?

Phylos Bioscience's latest funding was a $***** Series B round on Dec 31, 2025, with participation from 1 investor.

Where does Phylos Bioscience rank among its competitors?

Phylos Bioscience ranks 3rd amongst 484 active competitors, of which 97 are funded. It stands 5th in terms of total funding among its competitors. The most recent competitor to raise funding was Computomics, which secured $7.3M in Aug, 2026.

Who are the top competitors of Phylos Bioscience?

Phylos Bioscience's top competitors include Advanta, Tropic Biosciences and Computomics. Among them, Computomics secured the most recent funding round in August, 2026.

Phylos Bioscience - 2026 Company Profile, Team, Funding & Competitors

Phylos Bioscience is a series B company based in Portland (United States), founded in 2014 by Mowgli Holmes. It operates as a Developer of cannabis F1 hybrid seeds and natural THC products. Phylos Bioscience has raised $31.2M in funding from Merida Capital Partners. The company has 484 active competitors, including 97 funded and 67 that have exited. Its top competitors include companies like Advanta, Tropic Biosciences and Computomics.

Company Details

Developer of cannabis F1 hybrid seeds and natural THC products. The company empowers growers to produce high-quality cannabis cost-effectively. It offers elite, phenotypically-stable, fully-feminized true F1 hybrid seed lines. The company's seed-grown plants rival the uniformity of clonal varieties for harvest height, wet biomass, and total THC. It provides insights on mitigating HLVd risk with F1 hybrid production-ready seeds.

Website: phylos.bio
Social
Email ID: *****@phylos.bio
Phone Number: +1 **********

Key Metrics

Founded Year

2014

Location

Portland, United States

Stage

Series B

Total Funding

$31.2M in 10 rounds

Latest Funding Round

Series B, Dec 31, 2025, $*****

Investors

Merida Capital Partners & 7 more

Ranked

3^rd among 484 active competitors

Employee Count

47 as on Sep 30, 2026

Similar Companies

Advanta & 308 more

View Phylos Bioscience's full profile

Phylos Bioscience is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
Phylos Bioscience, Inc. CIN: 46-4844470 , United States, Active	Feb 23, 2017	-	61 (As on Dec 31, 2020)	-

Phylos Bioscience has raised a total funding of $31.2M over 10 rounds. Its first funding round was on Jan 20, 2015. Its latest funding round was a Series B round on Dec 31, 2025 for $*****. 1 investor participated in its latest round. Phylos Bioscience has 8 institutional investors.

Here is the list of recent funding rounds of Phylos Bioscience:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Dec 31, 2025	3850527	Series B	1481034	7800755	1797650	4261700
Oct 15, 2024	8094682	Series B	3638977	3432574	1088460	2157914
Nov 01, 2023	5994684	Series B	3373532	9342612	3376833	5010668

Access funding benchmarks and valuations. Sign up today!

View details of Phylos Bioscience's funding rounds and investors

The founders of Phylos Bioscience is Mowgli Holmes.

Here are the details of Phylos Bioscience's key team members:

Mowgli Holmes: Co-Founder & CEO of Phylos Bioscience.

View details of Phylos Bioscience's Founder profiles and Board Members

Phylos Bioscience's employee count trend

Phylos Bioscience has 47 employees as of Sep 26. Here is Phylos Bioscience's employee count trend over the years:

Employee count trend for Phylos Bioscience

Uncover Phylos Bioscience's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Phylos Bioscience include Advanta, Tropic Biosciences and Computomics. Here is the list of Top 10 competitors of Phylos Bioscience, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Advanta 1989, Dubai (United Arab Emirates), Public	Developer of high-nutrition crops for sustainable agriculture	$400M	KKR, Alpha Wave Global & 5 others	72/100
2nd	Tropic Biosciences 2016, Norwich (United Kingdom), Series C	Developer of gene editing technologies for improved tropical crop production	$179M	Temasek, Aliment Capital & 39 others	68/100
3rd	Phylos Bioscience 2014, Portland (United States), Series B	Developer of cannabis F1 hybrid seeds and natural THC products	$31.2M	Accomplice, V. Gastevich Investments & 6 others	60/100
4th	Computomics 2012, Tubingen (Germany), Series B	Provider of data analysis services for next-generation sequencing data for the crop science industry	$7.85M	BASF, Convent Capital & 8 others	60/100
5th	Evogene 2002, Rehovot (Israel), Public	Developer of computational tools for pharmaceutical and agricultural industries	-	Shavit Capital, GlenRock Israel & 4 others	58/100
6th	Pairwise 2017, Durham (United States), Series C	Provider of gene editing technology for climate-resilient, nutritious, and sustainable crops	$155M	Deerfield, Aliment Capital & 5 others	57/100
7th	Renaissance BioScience 2013, Vancouver (Canada), Series A	Developer of bioengineering technology for agriculture, food, health, and industrial markets	$5M	Northview LifeSciences, Carpere Capital Management ... & 2 others	57/100
8th	Biographica 2022, London (United Kingdom), Seed	Computational Platform for gene discovery and editing	$9.5M	Faber, Entrepreneurs First & 4 others	57/100
9th	Cibus 2001, San Diego (United States), Public	Developer of precision breeding technologies for resilient and vigorous crops	$34.5M	Fidelity Investments, Qubis & 7 others	57/100
10th	Plastomics 2016, St. Louis (United States), Series B	Developer of next-generation trait delivery technology for higher-yielding crops and sustainable agriculture	$18.5M	Lewis & Clark Agrifood, BioGenerator & 21 others	56/100